Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial

OBJECTIVES: Systemic sclerosis (SSc) is an auto-immune, multi organ disease marked by severe gastrointestinal (GI) involvement and gut dysbiosis. Here, we aimed to determine the safety and efficacy of fecal microbiota transplantation (FMT) using commercially-available anaerobic cultivated human inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Fretheim, Håvard, Chung, Brian K., Didriksen, Henriette, Bækkevold, Espen S., Midtvedt, Øyvind, Brunborg, Cathrine, Holm, Kristian, Valeur, Jørgen, Tennøe, Anders Heiervang, Garen, Torhild, Midtvedt, Tore, Trøseid, Marius, Zarè, Hasse, Lund, May Brit, Hov, Johannes R., Lundin, Knut E. A., Molberg, Øyvind, Hoffmann-Vold, Anna-Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241803/
https://www.ncbi.nlm.nih.gov/pubmed/32437393
http://dx.doi.org/10.1371/journal.pone.0232739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241803/
https://www.ncbi.nlm.nih.gov/pubmed/32437393
http://dx.doi.org/10.1371/journal.pone.0232739

Ejemplares similares